baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

FUJI CORP./ JP3809200003 /

2024-05-22 8:05:02 AM	Chg. +0.1000	Volume	Bid8:17:03 AM	Ask8:05:04 AM	High	Low
15.0000EUR	+0.67%	0 Turnover: 0.0000	14.9000Bid Size: 150	15.9000Ask Size: 140	15.0000	15.0000

GlobeNewswire 05-21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

GlobeNewswire 05-21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...

GlobeNewswire 05-21 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

GlobeNewswire 05-16 Blue World Acquisition Corporation Announces the Redemption Deadline as May 23, 2024 for the Extraor...

GlobeNewswire 05-13 Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...

GlobeNewswire 05-02 Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

GlobeNewswire 04-30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...

GlobeNewswire 04-24 Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...

GlobeNewswire 04-19 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...

GlobeNewswire 04-16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...

GlobeNewswire 04-15 Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Busin...

GlobeNewswire 04-03 Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024

GlobeNewswire 04-03 Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combi...

GlobeNewswire 03-22 Alvotech Announces Increase in Number of Own Shares

GlobeNewswire 03-20 Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update

GlobeNewswire 03-14 Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

GlobeNewswire 03-05 Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET

GlobeNewswire 03-04 Terrata Homes Expands Presence with A New Community in Seattle

GlobeNewswire 02-29 Alvotech Appoints Interim Chief Quality Officer

GlobeNewswire 02-29 Golar LNG Limited preliminary fourth quarter and financial year 2023 results

GlobeNewswire 02-26 Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...

GlobeNewswire 02-24 Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interc...

GlobeNewswire 02-20 Official 24 Hours of Le Mans Game, Le Mans Ultimate, available today

GlobeNewswire 02-15 Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)

GlobeNewswire 02-14 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji

FUJI CORP./ JP3809200003 /

If you wish to receive reply to your feedback, please provide your email address.